Ecology and industrial microbiology by Demain, A.L & Dijkhuizen, L.
  
 University of Groningen
Ecology and industrial microbiology
Demain, A.L; Dijkhuizen, L.
Published in:
Current Opinion in Microbiology
DOI:
10.1016/j.mib.2006.04.009
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2006
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Demain, A. L., & Dijkhuizen, L. (2006). Ecology and industrial microbiology. Current Opinion in
Microbiology, 9(3), 237 - 239. https://doi.org/10.1016/j.mib.2006.04.009
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Ecology and industrial microbiology
Editorial overview
Arnold L Demain and Lubbert Dijkhuizen
Current Opinion in Microbiology 2006, 9:237–239Available online 9th May 2006
1369-5274/$ – see front matter
Published by Elsevier Ltd.
DOI 10.1016/j.mib.2006.04.009‘
Arnold L Demain
Research Institute for Scientists Emeriti (RISE),
Drew University, Madison, NJ 07940, USA
e-mail: ademain@drew.edu
Arnold L Demain, after careers at
Merck & Co and MIT, is Research
Fellow in Microbial Biochemistry at
Drew University. His research
interests are industrial fermentations
and biotechnology.
Lubbert Dijkhuizen
Department of Microbiology, University of





Lubbert Dijkhuizen is currently
director of the Groningen
Biomolecular Sciences and
Biotechnology (GBB) research
institute and graduate school. His




and differentiation) in actinomycetes,
and structure/function relationships of
protein with emphasis on
carbohydrate acting enzymes.www.sciencedirect.comAlthough traditional industrial microbiology has been in practice for cen-
turies, yielding interesting foods, drinks and condiments, a new era began
early in the 20th century that featured the microbial production of several
new products, such as organic acids, solvents, vitamins and enzymes.
Bursting onto the scene in the middle of this century were the antibiotics
and antitumor compounds, which were produced in large-scale fermenters
and which revolutionized the practice of medicine. From the 1950s to the
1980s, new antibiotics and anticancer agents were rolled-out by the phar-
maceutical industry, one after another, so that natural compounds or their
derivatives represented half of the new pharmaceutical products being
produced. Despite the advances in molecular biology since the 1950s,
the development of recombinant DNA and the birth of the biotechnology
business in the early 1970s, the discovery of new natural products useful in
medicine has slowed down. At the same time, the total number of drugs
submitted to the regulatory agencies, and the number of these drugs that are
approved has dropped continuously, despite major increases in money spent
on research and development. This is probably because of a number of
events: the mega-mergers of the pharmaceutical industry, the major com-
mitment of these companies to combinatorial chemistry and high-through-
put screening, and the huge amounts of money spent on elucidation of the
human and other genomes. Whatever the reason, it is clear that we must
return to the search for natural products, but not in the same way; we must
employ new techniques to find novel therapeutics, novel enzymes and we
must modernize the methods of improving industrial microbial strains.
Today, another area of great importance is microbial ecology, especially
involving the study of the diversity and functionality of microbial commu-
nities in natural andmanmade environments, for instance in industrial-waste
treatment reactors. Many microbes are able to live in biofilm communities;
their use of chemical communication is fascinating and deserves consider-
able attention. Finally, a detailed understanding of the regulation of viru-
lence and persistence of microbes of importance to bioterrorism appears
crucial. Microbial ecology and industrial microbiology have come closer
together in recent years as a result of the discovery that the vast number of
microbial species (95–99.9%) has not yet been grown in the laboratory and
that studies of biodiversity and biogeography offer the potential to lead us to
discover new processes and novel natural products.
The vast abundance of as-yet undiscovered bioactive natural compounds
will provide the drugs of the future, as well as new applications in agriculture
and industry; of this there is no doubt. One very exciting source is the
endophytic microbes living in the tissues of plants. Strobel has been working
for many years on microbial diversity in the rainforests of the world, andCurrent Opinion in Microbiology 2006, 9:237–239
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and bacteria exist and thrive. He has discovered many
novel compounds, but in his review here, he focuses on a
single fungal genus, Muscador, and its ability to produce
volatile organic bioactive compounds. These exciting
compounds can inhibit many pathogenic fungi and bac-
teria, and synergistically are lethal. He discusses the
discovery of this genus, the compounds produced, the
physiology of their production and the new concept of
‘‘mycofumigation’’; commercial agricultural products
based on this discovery are on their way.
Another relatively untapped source of new microorgan-
isms and novel products is the marine environment.
Indeed, the greatest biodiversity in the world is found
in the oceans. Findings that new deep-sea microbes exist
that are different from their terrestrial counterparts have
sparked new enthusiasm in this search and discovery
effort. New genera of filamentous bacteria (actinomy-
cetes) have been identified, some of which require salt
for growth. This has surprised many who thought that
actinomycetes isolated from the marine environment
merely represented re-growth of spores of terrestrial soil
actinomycetes, washed into the sea. These marine acti-
nomycetes include the new genera Salinispora and Mar-
inospora, which mostly produce novel secondary
metabolites. Lam leads us through this exciting devel-
opment and its tremendous potential, discussing indigen-
ous marine actinomycetes, their distribution, and their
novel metabolites of potential industrial significance.
Another means of improving the drug discovery process is
through microbial genomics. Understanding of the genet-
ics and genomics of natural product synthesis has boomed
in the last ten to twenty years and has provided much
insight into the ways these interesting compounds are
made by microorganisms. Clustering of the relevant
genes and biosynthetic enzymes has allowed the discov-
ery of many new derivatives of old compounds, and of
novel compounds known as ‘unnatural natural products’.
This area of research, combinatorial biosynthesis, offers
great hope for the future as long as production titres of the
new compounds can be increased, and broad activity-
testing is available. Increases in titres could possibly be
brought about by cloning the gene clusters into hosts that
are capable of higher levels of secondary metabolite
synthesis. The cloning of environmental DNA (known
as metagenomics) into known organisms has also yielded
novel compounds. Genomics studies have shown us that
there are many more clusters of secondary metabolism
genes in a single microbial strain than are needed for
synthesis of the few products known to be produced by
that strain. Van Lanen and Shen cover these possibilities
in a comprehensive way and describe important areas
such as whole genome sequence mining, genome scan-
ning, cultivation andmetagenomics, heterologous expres-
sion and the discovery of novel chemistry.Current Opinion in Microbiology 2006, 9:237–239Directed evolution of enzymes is an area of increasing
interest in industrial circles. For exploring sequence
space of enzymes and creating novel enzymes, a combi-
nation of directed evolution and computational design is
discussed by Johannes and Zhao. They remind us that
many steps in industrial synthetic chemistry are carried
out by biocatalysts and that over 500 products from
numerous industries involve biocatalysis. They focus
on developments over the last two years. Directed evolu-
tion, unlike rational design, depends on mutation and
selection, not on the relation between enzyme structure
and function. It involves error-prone PCR, DNA shuf-
fling, saturation mutagenesis and high-throughput
screening. Not only can improved enzymes — improved
in activity, stability, selectivity, solubility and optima for
pH and temperature — be created, but pathways can be
manipulated by metabolic engineering and directed evo-
lution to yield novel secondary metabolites for the phar-
maceutical, chemical and food industries.
Production of organic acids, amino acids and ethanol are
the focus of Wendisch, Bott and Eikmanns review. They
show us how metabolic engineering has been applied to
create new recombinant strains of Escherichia coli and
Corynebacterium glutamicum that are of interest to industry.
These two species of bacteria have been studied for many
years providing knowledge of their carbon metabolism
and their physiology, thus allowing efficient application of
metabolic engineering. The compounds of particular
interest in this contribution are acetate, pyruvate, lactate,
succinate, lysine, serine and ethanol.
Wastewater bioreactors contain microbial communities
that are of a similar complexity to those in a variety of
natural environments. Bramucci and Nagarajan review
progress towards a better understanding of microbial
communities in industrial wastewater bioreactors. As
previously observed for natural environments, only a
small portion of the population in wastewater bioreactors
can be isolated and grown as pure microbial strains in the
laboratory. Recent advances in molecular tools increas-
ingly enable identification and characterization of the
microbes in these bioreactors. The challenge now facing
wastewater engineers and microbiologists is to relate
microbial community analysis to the metabolic function
of specific groups of bacteria within a wastewater bio-
reactor. The unique growth conditions in these bioreac-
tors also facilitate formation of novel biochemical
pathways through horizontal gene transfer and recruit-
ment of different genes from diverse hosts into a single
host. Thus, wastewater is a very promising source for new
biocatalysts.
Marinemicrobial ecology is making striking advances; the
marine environment has emerged as a prime resource for
the isolation of novel organisms and novel chemistry in
search and discovery. Ward and Bora review the diversitywww.sciencedirect.com
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views of actinobacterial diversity have emerged from
cultivation and molecular approaches. Habitats in the
marine environment are diverse, and vary greatly in
geophysical characteristics. The biogeographic data for
marine actinomycetes that has become available in recent
years is discussed; this data are highly relevant with
respect to practical implications, defining clear strategies
for search and discovery, but also with major ecological
and evolutionary implications.
Bacterial cell–cell communication by small signalling
molecules has been intensively studied in the last decade.
The first signalling molecules to be identified were the g-
butyrolactones from Streptomyces. These are fascinating
compounds, which mainly regulate the production ofwww.sciencedirect.comantibiotics and cellular differentiation. Takano reviews
new insights into their synthesis and degradation, and the
molecular mechanism of the g-butyrolactone regulatory
system. These signal molecules are produced in a diver-
sity of actinomycetes. Current evidence indicates that
they are widespread regulators of antibiotic production in
actinomycetes. The importance of understanding how
secondary metabolites are regulated, and how environ-
mental and physiological signals are sensed, highlights
the relevance of studying this system.
The various reviews in this issue, written by specialists in
their respective fields, provide very interesting reading,
representing strong progress in knowledge and under-
standing of these fields and providing fundamental
insights in the topics under study.Current Opinion in Microbiology 2006, 9:237–239
